Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1988-03-14
1989-04-25
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540595, C07D22316, A61K 3155
Patent
active
048248398
ABSTRACT:
Sulfinyl and sulfonyl substituted 3-benzazepine compounds are useful in treating gastrointestinal motility disorders and emesis. A particular compound of this invention is 7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine.
REFERENCES:
patent: 3689649 (1972-09-01), Dietrich
patent: 4514394 (1985-04-01), Chambers et al.
Bondinell William E.
Ormsbee, III Herbert S.
Hall Linda E.
Lourie Alan D.
SmithKline Beckman Corporation
Springer David B.
Williams Janice E.
LandOfFree
Sulfinyl and sulfonyl substituted 2,3,4,5 tetrahydro-1H-3-benzaz does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfinyl and sulfonyl substituted 2,3,4,5 tetrahydro-1H-3-benzaz, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfinyl and sulfonyl substituted 2,3,4,5 tetrahydro-1H-3-benzaz will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1195937